Pages that link to "Q30303621"
Jump to navigation
Jump to search
The following pages link to Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease (Q30303621):
Displaying 50 items.
- Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial (Q22242637) (← links)
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals (Q22299426) (← links)
- Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis (Q24197984) (← links)
- Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease (Q24202688) (← links)
- Weight reduction for non-alcoholic fatty liver disease (Q24235200) (← links)
- Weight reduction for non-alcoholic fatty liver disease (Q24236500) (← links)
- Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis (Q24243033) (← links)
- Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis (Q24243125) (← links)
- Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis (Q24245251) (← links)
- Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis (Q24246447) (← links)
- Nonalcoholic fatty liver disease (Q24555779) (← links)
- Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study (Q24596256) (← links)
- Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link (Q24631619) (← links)
- Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis (Q24815160) (← links)
- The Natural Course of Non-Alcoholic Fatty Liver Disease (Q26746947) (← links)
- Surveillance for Hepatocellular Carcinoma in Patients with NASH (Q26747428) (← links)
- Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma (Q26781477) (← links)
- Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways (Q26783372) (← links)
- Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma (Q26795529) (← links)
- Fructose as a key player in the development of fatty liver disease (Q27014596) (← links)
- Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis (Q27022707) (← links)
- Prevalence and determinants of biochemical dysfunction of the liver in Atayal Aboriginal community of Taiwan: Is betel nut chewing a risk factor? (Q27486400) (← links)
- Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis (Q27489394) (← links)
- Metabolic and cardiovascular complications in the liver transplant recipient (Q28082243) (← links)
- Liver fibrosis in overweight patients (Q28145482) (← links)
- Non-alcoholic fatty liver disease: need for a balanced nutritional source (Q28248994) (← links)
- Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994 (Q28384968) (← links)
- Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations (Q28386598) (← links)
- The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma (Q28392224) (← links)
- Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice (Q28476015) (← links)
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity (Q28512778) (← links)
- The global epidemiology of hepatocellular carcinoma: present and future (Q28654353) (← links)
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults (Q29614911) (← links)
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease (Q29614930) (← links)
- NAFLD and liver transplantation: Current burden and expected challenges (Q30248646) (← links)
- A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis (Q30306955) (← links)
- Is NASH underdiagnosed among African Americans? (Q30309598) (← links)
- Subacute liver failure in obese women (Q30309852) (← links)
- Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis (Q30368738) (← links)
- Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology (Q30389752) (← links)
- The effects of diet composition on body fat and hepatic steatosis in an animal (Peromyscus californicus) model of the metabolic syndrome (Q30431218) (← links)
- The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis (Q30433447) (← links)
- Cryptogenic cirrhosis: what are we missing? (Q30450710) (← links)
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (Q30479629) (← links)
- Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes (Q30496725) (← links)
- Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study (Q31107490) (← links)
- Identification of novel molecular candidates for fatty liver in the hyperlipidemic mouse model, HcB19. (Q33200804) (← links)
- Increased hepatic UCP2 expression in rats with nonalcoholic steatohepatitis is associated with upregulation of Sp1 binding to its motif within the proximal promoter region (Q33342303) (← links)
- Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease (Q33401299) (← links)
- Assessment of NAFLD cases and its correlation to BMI and metabolic syndrome in healthy blood donors in Kerman (Q33596430) (← links)